The outbreak of the Bundibugyo strain, first detected in DR Congo in May, has killed more than 4,600 people, according to Africa CDC director-general Jean Kaseya, speaking to Semafor. Health experts believe the virus had been circulating undetected for weeks before it was identified.
Nigeria, Africa’s most populous country, confirmed its first case of the strain, for which there is no proven vaccine. The patient is a woman who traveled from Uganda and went roughly 10 days without being tested, moving between two private facilities. Nigeria’s health minister, Muhammad Ali Pate, told reporters late on Thursday that authorities had found no evidence the virus had spread into communities. "This is a contained single case, and we are diligently working to ensure that it remains so," he said.
Kenya has reported nine cases and isolated its first patient soon after arrival, Kaseya said. Uganda recorded 20 cases but was declared Ebola-free in August.
Kaseya said the outbreak had initially been viewed as less dangerous and easier to contain, with little expectation that it would spread to other African regions, a judgment that proved wrong. He warned against closing borders as a containment measure. "We do not recommend border closures," he said, arguing they would push people onto informal, unofficial routes.
Health, finance and transport ministers are due to meet next week, with regional organizations invited, to discuss national and cross-border measures. Kaseya said he expects a response plan dividing responsibilities among partners to be ready by then, ahead of a summit of African leaders where he hopes to secure funding commitments.
The spread comes against the backdrop of deep cuts to Western aid budgets, which health experts say have reduced the presence of health workers on the ground. The UN’s senior Ebola coordinator, Jullien Harneis, told Semafor the outbreak’s geographic spread posed a real management challenge.
Africa CDC warned last week that aid organizations had not reported more than $700 million in donor funding to Congolese authorities. Kaseya said $450 million had since been traced, and the agency backed government sanctions, including withdrawing permission to operate, against organizations that continued to refuse to account for their funds.
This outbreak is the second deadliest in history after the 2014-16 epidemic that killed more than 11,300 people. The Ervebo vaccine, effective against another species of Ebola, is being tested against the Bundibugyo strain and has been administered to 9,000 frontline workers.